Skip to main content
Year archive

Checkpoint Trends Limited — 2022 filings

All 35 regulatory filings released by Checkpoint Trends Limited (531099) in 2022, sourced directly from the official regulator.

35 Filings
2022 Period
2022 filings (35)
Filing Released Lang
The Trading Window for dealing in the Company''s Equity Shares will remain closed from Sunday, January 1, 2023 for all Designated Employees of the Company. The closure is in connection ....
Regulatory Filings
2022-12-28 English
Resignation and Appointment of Company Secretary and Compliance Officer
Regulatory Filings
2022-12-07 English
Submission of newspaper publication of unaudited Financial Results for the quarter and half year ended September 30, 2022
Regulatory Filings
2022-11-14 English
1. This is to inform you that, the Board of Directors of the Company at its meeting held on Thursday, November 10, 2022 inter alia, has considered and approved the following: A. ....
Regulatory Filings
2022-11-14 English
As per Regulation 23(9) of SEBI (LODR) Regulations, 2015, please find attached herewith disclosures of related party transactions for the half year ended September 30, 2022.
Regulatory Filings
2022-11-10 English
Standalone Unaudited Financial Results along with limited review report, Asset and liability statement and Cash Flow Statement of the Company for the half year ended September 30, 2022.
Regulatory Filings
2022-11-10 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve Standalone Unaudited Financial ....
Regulatory Filings
2022-10-28 English
Scrutinizer''s Report
Regulatory Filings
2022-10-01 English
Voting results of 31st Annual General Meeting held on September 30, 2022
Regulatory Filings
2022-10-01 English
Pursuant to the Company''s Securities Dealing Code, the Trading Window for dealing in the Company''s Equity Shares will remain closed from Saturday, October 1, 2022 for all Designated Employees ....
Regulatory Filings
2022-09-27 English
Submission of newspaper publication of notice of Annual General Meeting Date of AGM - September 30, 2022
Regulatory Filings
2022-09-05 English
Annual Report of the Company for the FY 2021-22
Regulatory Filings
2022-09-03 English
In compliance with Regulation 29 of the SEBI (LODR) Regulations, 2015, please find attached herewith Notice of Annual General Meeting Date of Annual General Meeting - September 30, 2022.
Regulatory Filings
2022-09-03 English
Submission of newspaper publication of unaudited Financial Results for the quarter ended June 30, 2022
Regulatory Filings
2022-08-16 English
Outcome of Board Meeting
Regulatory Filings
2022-08-11 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 ,inter alia, to consider and approve 1. Standalone Unaudited ....
Regulatory Filings
2022-08-01 English
The Trading Window for dealing in the Company''s Equity Shares will remain closed from Friday, July 1, 2022 for all Designated Employees of the Company. The closure is in connection ....
Regulatory Filings
2022-06-28 English
Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2022
Regulatory Filings
2022-06-02 English
Submission of newspaper publication of audited Financial Results for the quarter and year ended March 31, 2022
Regulatory Filings
2022-05-28 English
Related Party Disclosure for the half year ended March 31, 2022
Regulatory Filings
2022-05-25 English
This is to inform you that the Board of Directors of the Company at its meeting held on Wednesday, May 25, 2022, inter alia, has considered and approved the following: A. Audited ....
Regulatory Filings
2022-05-25 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve The Standalone Audited Financial ....
Regulatory Filings
2022-05-13 English
Initial Disclosure to be made by an entity which is not a Large Corporate
Regulatory Filings
2022-04-15 English
Compliance Certificate pursuant to Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the half year ended March 31, 2022
Regulatory Filings
2022-04-15 English
The Certificate under Regulation 40(9) of the SEBI (LODR) Regulations, 2015 for the half year ended March 31, 2022 given by Practising Company Secretary
Regulatory Filings
2022-04-11 English
Report of Scrutinizer on Outcome of Postal Ballot for:- I. Change in name of the Company to new name. II. Addition of new object in the main object of the company.
Regulatory Filings
2022-04-06 English
Approval of the shareholders by way of Postal Ballot for:- I. Change in name of the Company to new name. II. Addition of new object in the main object of the company.
Regulatory Filings
2022-04-06 English
Pursuant to the Company''s Securities Dealing Code, the Trading Window for dealing in the Company''s Equity Shares will remain closed from Friday, April 1, 2022 for all Designated Employees ....
Regulatory Filings
2022-03-30 English
Submission of newspaper publication of Notice of Postal Ballot
Regulatory Filings
2022-03-09 English
This is to inform you that the Board of Directors of the Company at its meeting held on Friday, March 4, 2022, inter alia, has considered and approved the following: A. Addition of new ....
Regulatory Filings
2022-03-04 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/03/2022 ,inter alia, to consider and approve Addition of new object in ....
Regulatory Filings
2022-02-24 English
Submission of newspaper publication of Unaudited Financial Results for the quarter and Nine Month ended December 31, 2021
Regulatory Filings
2022-02-15 English
This is to inform you that the Board of Directors of the Company at its meeting held on Friday, February 11, 2022, inter alia, has considered and approved the following: A. Unaudited ....
Regulatory Filings
2022-02-11 English
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 ,inter alia, to consider and approve This is to inform you that ....
Regulatory Filings
2022-02-02 English
Pursuant to the Company''s Securities Dealing Code, the Trading Window for dealing in the Company''s Equity Shares will remain closed from Saturday, January 1, 2022 for all Designated Employees ....
Regulatory Filings
2022-01-03 English